Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study.

Nordlund A, Rolstad S, Klang O, Edman A, Hansen S, Wallin A.

J Neurol Neurosurg Psychiatry. 2010 May;81(5):541-6. doi: 10.1136/jnnp.2008.171066. Epub 2009 Dec 3.

PMID:
19965857
2.

Predicting the time of conversion to MCI in the elderly: role of verbal expression and learning.

Oulhaj A, Wilcock GK, Smith AD, de Jager CA.

Neurology. 2009 Nov 3;73(18):1436-42. doi: 10.1212/WNL.0b013e3181c0665f. Epub 2009 Sep 30.

3.

Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts.

Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C.

Arch Neurol. 2009 Sep;66(9):1151-7. doi: 10.1001/archneurol.2009.106.

4.

Selectivity of executive function deficits in mild cognitive impairment.

Brandt J, Aretouli E, Neijstrom E, Samek J, Manning K, Albert MS, Bandeen-Roche K.

Neuropsychology. 2009 Sep;23(5):607-18. doi: 10.1037/a0015851.

5.

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K.

JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.

PMID:
19622817
6.

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM.

N Engl J Med. 2009 Jul 16;361(3):255-63. doi: 10.1056/NEJMoa0809437.

7.

Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm.

Mitchell J, Arnold R, Dawson K, Nestor PJ, Hodges JR.

J Neurol. 2009 Sep;256(9):1500-9. doi: 10.1007/s00415-009-5152-0. Epub 2009 May 12.

PMID:
19434441
8.

Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period.

Loewenstein DA, Acevedo A, Small BJ, Agron J, Crocco E, Duara R.

Dement Geriatr Cogn Disord. 2009;27(5):418-23. doi: 10.1159/000211803. Epub 2009 Apr 9.

9.

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

Mitchell AJ, Shiri-Feshki M.

Acta Psychiatr Scand. 2009 Apr;119(4):252-65. doi: 10.1111/j.1600-0447.2008.01326.x. Epub 2008 Feb 18.

PMID:
19236314
10.

Predictive value of mild cognitive impairment for dementia. The influence of case definition and age.

Baars MA, van Boxtel MP, Dijkstra JB, Visser PJ, van den Akker M, Verhey FR, Jolles J.

Dement Geriatr Cogn Disord. 2009;27(2):173-81. doi: 10.1159/000200465. Epub 2009 Feb 7.

PMID:
19202336
11.

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.

Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.

Neurology. 2009 May 5;72(18):1555-61. doi: 10.1212/01.wnl.0000344650.95823.03. Epub 2009 Jan 28.

PMID:
19176895
12.

Treatment for MCI: is the evidence sufficient?

Aisen PS.

Neurology. 2008 May 27;70(22):2020-1. doi: 10.1212/01.wnl.0000313380.89894.54. No abstract available.

PMID:
18505976
13.

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW.

J Magn Reson Imaging. 2008 Apr;27(4):685-91. doi: 10.1002/jmri.21049.

14.

Frequency and course of mild cognitive impairment in a multiethnic community.

Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R.

Ann Neurol. 2008 Apr;63(4):494-506. doi: 10.1002/ana.21326.

15.

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.

Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C.

J Int Neuropsychol Soc. 2008 Mar;14(2):266-78. doi: 10.1017/S1355617708080302.

16.

Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.

Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D.

Arch Gen Psychiatry. 2007 Dec;64(12):1443-50.

17.

Executive functioning in older adults with mild cognitive impairment: MCI has effects on planning, but not on inhibition.

Zhang Y, Han B, Verhaeghen P, Nilsson LG.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007 Nov;14(6):557-70. Erratum in: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2008 Mar;15(2):256.

PMID:
18038355
18.

Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population.

Ravaglia G, Forti P, Montesi F, Lucicesare A, Pisacane N, Rietti E, Dalmonte E, Bianchin M, Mecocci P.

J Am Geriatr Soc. 2008 Jan;56(1):51-8. Epub 2007 Nov 20.

PMID:
18028343
19.

Should one use medications in combination with cognitive training? If so, which ones?

Yesavage J, Hoblyn J, Friedman L, Mumenthaler M, Schneider B, O'Hara R.

J Gerontol B Psychol Sci Soc Sci. 2007 Jun;62 Spec No 1:11-8. Review.

PMID:
17565161
20.

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.

Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2007 Dec;22(12):1217-22.

PMID:
17562522

Supplemental Content

Support Center